ESHBAL FUNCTIONAL FOOD INC (ESBL.CA) Stock Fundamental Analysis

TSX-V:ESBL • CA2959181066

0.155 CAD
+0.01 (+3.33%)
Last: Feb 24, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ESBL. ESBL was compared to 0 industry peers in the Unkown industry. ESBL may be in some trouble as it scores bad on both profitability and health. ESBL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year ESBL has reported negative net income.
  • In the past year ESBL had a positive cash flow from operations.
  • In the past 5 years ESBL always reported negative net income.
  • In the past 5 years ESBL always reported negative operating cash flow.
ESBL.CA Yearly Net Income VS EBIT VS OCF VS FCFESBL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50K -100K

1.2 Ratios

Industry RankSector Rank
ROA -4.99%
ROE -20.58%
ROIC 18.75%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESBL.CA Yearly ROA, ROE, ROICESBL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Gross Margin are not available for ESBL so they could not be analyzed.
Industry RankSector Rank
OM 25.15%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ESBL.CA Yearly Profit, Operating, Gross MarginsESBL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ESBL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ESBL.CA Yearly Shares OutstandingESBL.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
ESBL.CA Yearly Total Debt VS Total AssetsESBL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 200K 400K 600K 800K 1M

2.2 Solvency

  • Based on the Altman-Z score of 1.05, we must say that ESBL is in the distress zone and has some risk of bankruptcy.
  • ESBL has a Debt/Equity ratio of 0.78. This is a neutral value indicating ESBL is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACCN/A
ESBL.CA Yearly LT Debt VS Equity VS FCFESBL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200K 400K 600K 800K 1M

2.3 Liquidity

  • ESBL has a Current Ratio of 1.32. This is a normal value and indicates that ESBL is financially healthy and should not expect problems in meeting its short term obligations.
  • ESBL has a Quick Ratio of 1.32. This is a bad value and indicates that ESBL is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.95
ESBL.CA Yearly Current Assets VS Current LiabilitesESBL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ESBL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.65%, which is quite impressive.
  • The Revenue has grown by 14640.37% in the past year. This is a very strong growth!
EPS 1Y (TTM)39.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.64%
Revenue 1Y (TTM)14640.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%53503.17%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESBL.CA Yearly Revenue VS EstimatesESBL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • ESBL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESBL.CA Price Earnings VS Forward Price EarningsESBL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESBL.CA Per share dataESBL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ESBL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ESHBAL FUNCTIONAL FOOD INC

TSX-V:ESBL (2/24/2026, 7:00:00 PM)

0.155

+0.01 (+3.33%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-02
Earnings (Next)05-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners73.1%
Ins Owner ChangeN/A
Market Cap10.56M
Revenue(TTM)6.35M
Net Income(TTM)-598.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.21
P/FCF N/A
P/OCF 67.65
P/B 2.65
P/tB 2.91
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFY1.48%
SpS0.13
BVpS0.06
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.99%
ROE -20.58%
ROCE 26.04%
ROIC 18.75%
ROICexc 21.53%
ROICexgc 22.63%
OM 25.15%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.95
Altman-Z 1.05
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.64%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14640.37%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%53503.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y690.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y254.55%
OCF growth 3YN/A
OCF growth 5YN/A

ESHBAL FUNCTIONAL FOOD INC / ESBL.CA FAQ

What is the ChartMill fundamental rating of ESHBAL FUNCTIONAL FOOD INC (ESBL.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ESBL.CA.


Can you provide the valuation status for ESHBAL FUNCTIONAL FOOD INC?

ChartMill assigns a valuation rating of 0 / 10 to ESHBAL FUNCTIONAL FOOD INC (ESBL.CA). This can be considered as Overvalued.


Can you provide the profitability details for ESHBAL FUNCTIONAL FOOD INC?

ESHBAL FUNCTIONAL FOOD INC (ESBL.CA) has a profitability rating of 0 / 10.


How financially healthy is ESHBAL FUNCTIONAL FOOD INC?

The financial health rating of ESHBAL FUNCTIONAL FOOD INC (ESBL.CA) is 1 / 10.